GeoVax Labs (GOVX) Free Cash Flow (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Free Cash Flow of -$5.0 million for Q4 2025, up 36.01% year-over-year from -$3.6 million in Q4 2024, and up 20.13% quarter-over-quarter from -$6.2 million in Q3 2025.
GeoVax Labs (GOVX) Free Cash Flow (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Free Cash Flow for 16 consecutive years, with -$5.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Free Cash Flow rose 36.01% year-over-year to -$5.0 million; the TTM figure through Jun 2026 stood at -$15.5 million (up 43.36% YoY), while the FY2025 annual figure was -$21.5 million, up 12.94% from the prior year.
- Free Cash Flow advanced to -$5.0 million in Q4 2025 per GOVX's latest filing, from -$6.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$1.3 million in Q2 2021 and bottomed at -$10.3 million in Q4 2023.
- Historically, Free Cash Flow has averaged -$5.1 million across 5 years, with a median of -$5.0 million in 2023.
- Annual changes were most pronounced in 2021 — Free Cash Flow tumbled 481.76% — and 2024, when it soared 67.97%.
- GeoVax Labs' Free Cash Flow stood at -$6.7 million in 2021, then slipped by 5.7% to -$7.1 million in 2022, then tumbled by 45.76% to -$10.3 million in 2023, then increased by 24.7% to -$7.8 million in 2024, then surged by 36.01% to -$5.0 million in 2025.
- Business Quant data shows GOVX's Free Cash Flow at -$5.0 million in Q4 2025, -$6.2 million in Q3 2025, and -$4.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.96 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Sep 30, 2025 | -6.21 Mn |
| Sep 30, 2025 | -6.21 Mn |
| Jun 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.35 Mn |
| Mar 31, 2025 | -5.98 Mn |
| Mar 31, 2025 | -5.98 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Dec 31, 2024 | -7.75 Mn |
| Sep 30, 2024 | -9.32 Mn |
| Sep 30, 2024 | -9.32 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -5.68 Mn |
| Mar 31, 2024 | -5.68 Mn |
| Dec 31, 2023 | -10.30 Mn |
| Dec 31, 2023 | -10.30 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |